Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal SN-38 in Small Cell Lung Cancer
NCT00104754Phase 2Withdrawn
- Sponsor
- Cancer and Leukemia Group B
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
01
Overview
A Phase 2 trial of LE-SN38 in small cell lung cancer (SCLC), sponsored by Cancer and Leukemia Group B. Status: withdrawn.
02
Drugs
LE-SN38
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00104754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00104754.